| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Carfilzomib |
|---|
| Description | Carfilzomib (PR-171) is a next generation, irreversible and selective inhibitor of the chymotrypsin-like activity of the proteasome. It displays potent antineoplastic activity. MW: 719.91. Purity ≥98% by HPLC |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (S)-4-methyl-N-((S)-1-((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-ylamino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide; PR-171 |
|---|
| Gene, Accession, CAS # | CAS: 868540-17-4 |
|---|
| Catalog # | 2385-25 |
|---|
| Price | |
|---|
| Order / More Info | Carfilzomib from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|